Dykema Guides TRxADE in Another Acquisition

Dykema congratulates TRxADE Health, Inc. on its business combination with Scienture, Inc., which represents a significant step towards the fulfillment of their mutual goal to market innovative pharmaceutical products that improve the standard of care for patients. TRxADE will rebrand as Scienture Holdings, Inc. and with continue trading on Nasdaq. This merger marks a significant move for both companies, as TRxADE transitions from focusing on digitalizing the retail pharmacy experience to expanding its reach in the specialty pharmaceutical market.